Bioxytran (BIXT) Gross Margin (2010 - 2018)
Bioxytran (BIXT) recorded Gross Margin of 60.04% in Q2 2018, up 9.18 percentage points from 50.86% a year earlier and up 74.56 percentage points from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Gross Margin (2010 - 2018) Analysis & Trends
On a TTM basis, Bioxytran's Gross Margin came in at 47.11% as of Jun 30, 2018, down 7.44 percentage points year-over-year; for FY2017, it came in at 45.58%, down 15.35 percentage points from FY2016.
- Annual Gross Margin has a five-year change of -15.45 percentage points (FY2012 to FY2017).
- Across earlier years, Gross Margin came in at 60.93% in FY2016 (+13.97 pp), 46.96% in FY2015 (+7.18 pp), 39.78% in FY2014 (-12.92 pp) and 52.70% in FY2013 (-8.33 pp).
- Quarterly Gross Margin has ranged from -83.88% in Q1 2017 to 76.72% in Q1 2015 over the past five years.
- On a year-over-year basis, Gross Margin rose in four of the last seven quarters, with an average year-over-year change of -16.64 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 383.89 percentage points in Q3 2013, against a drop of 130.57 percentage points in Q1 2017 at the low end.
- Per Business Quant, the preceding three quarters came in at -14.52% (Q1 2018), -20.49% (Q4 2017) and 71.52% (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 85.33% |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 60.04% |
| Mar 31, 2018 | -14.52% |
| Dec 31, 2017 | -20.49% |
| Sep 30, 2017 | 71.52% |
| Jun 30, 2017 | 50.86% |
| Mar 31, 2017 | -83.88% |
| Dec 31, 2016 | 61.39% |
| Sep 30, 2016 | 62.23% |
| Jun 30, 2016 | 66.15% |
| Mar 31, 2016 | 46.69% |
| Sep 30, 2015 | 38.80% |
| Jun 30, 2015 | 75.21% |
| Mar 31, 2015 | 76.72% |
| Sep 30, 2014 | 17.32% |
| Jun 30, 2014 | 68.29% |
| Mar 31, 2014 | 73.99% |
| Dec 31, 2013 | 46.61% |
| Sep 30, 2013 | 26.06% |
| Jun 30, 2013 | 55.89% |
| Mar 31, 2013 | 90.92% |
API Access
Bioxytran Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();